Following the company’s most recent results, RBC Dominion Securities analyst James McGarragle is feeling more bullish about ...

The announcement prompted ATB Capital Markets analyst Martin Toner to downgrade Docebo from “Outperform” to “Sector Perform” ...

Neal Gilmer is maintaining his “Buy” rating and C$21.00 target price, citing strong margins, robust cash flow and continued ...

Haywood Capital Markets analyst Neal Gilmer says Verano Holdings ( Verano Holdings Stock Quote, Chart, News, Analysts, ...

5N Plus’s quarterly revenue rose 36.7% year over year to $88.9-million, beating both Ventum’s $70.6-million and the Street’s ...

Beacon Securities analyst Russell Stanley reiterated his “Buy” rating and C$11.00 price target in a May 8 note.

Xtract One Technologies may be nearing a significant financial milestone, with Ventum Capital calling the security tech firm ...

Knight Therapeutics is continuing to build momentum, according to Stifel Nicolaus Canada analyst Justin Keywood.

In his May 7 corporate update, Leung remained bullish on Well Health’s positioning as a consolidator in Canada’s healthcare ...

Ballard Power’s disappointing Q1 2025 results prompted Roth Capital Partners analyst Craig Irwin to reaffirm his $1.25 price ...

ATB Capital Markets is sticking with its bullish view on Bitfarms, maintaining an Outperform rating and a $3.75 price target ...

Spectral is a clinical-stage medical device company focused on developing therapies for critical care, particularly septic ...